Cancer Type | # of SRGsa | DriverDBV3 | |||||
---|---|---|---|---|---|---|---|
Mutationb | CNV | Methylation | |||||
Log-Rank Test | |||||||
 KIRC | 7770 | 46.9% | (340/725) ** | 0% | (0/3) | 50% | (6/12) |
 LGG | 6691 | 32.5% | (570/1752) | 82.2% | (37/45) *** | – |  |
 ACC | 5243 | 19.7% | (74/375) | 32.3% | (40/124) | – |  |
 UVM | 3765 | 25% | (9/36) | 62% | (75/121) *** | – |  |
 LIHC | 2359 | 9.5% | (106/1113) | 9.6% | (8/83) | 6.6% | (12/181) |
 PRAD | 1538 | 5.1% | (58/1141) | 23.5% | (4/17) | 4.4% | (3/68) |
 MESO | 586 | 2.5% | (1/40) | 0% | (0/1) | – |  |
 PAAD | 443 | 1.6% | (16/971) | 0% | (0/2) | 16% | (4/25)** |
 KIRP | 238 | 1.9% | (12/631) | 1.1% | (1/87) | 2.2% | (5/224) |
 BLCA | 39 | 0.2% | (6/2404) | 0% | (0/104) | 0% | (0/443) |
 CESC | 35 | 0.2% | (4/1815) | 0% | (0/52) | – |  |
 LAML | 29 | 0% | (0/413) | 0% | (0/3) | – |  |
 HNSC | 18 | 0% | (0/1914) | 1% | (1/103) | 0% | (0/89) |
 STAD | 10 | 0.1% | (4/3695) | 0% | (0/86) | – |  |
 LUAD | 8 | 0% | (1/2903) | 0% | (0/37) | 0% | (0/18) |
 SKCM | 1 | 0% | (0/4559) | 0% | (0/18) | – |  |
Cox Regression | |||||||
 KIRC | 7091 | 38.3% | (278/725) | 0% | (0/3) | 50% | (6/12) |
 ACC | 6467 | 25.9% | (97/375) | 43.5% | (54/124) | – |  |
 UVM | 5600 | 33.3% | (12/36) | 84.3% | (102/121) *** | – |  |
 LGG | 5418 | 27.2% | (476/1752) | 42.2% | (19/45) *** | – |  |
 PAAD | 4287 | 21.2% | (206/971) | 0% | (0/2) | 36% | (9/25)* |
 LIHC | 2384 | 10% | (111/1113) | 8.4% | (7/83) | 9.9% | (18/181) |
 PRAD | 2068 | 8.1% | (92/1141) | 35.3% | (6/17) * | 5.9% | (4/68) |
 MESO | 728 | 2.5% | (1/40) | 0% | (0/1) | – |  |
 KIRP | 592 | 2.4% | (15/631) | 2.3% | (2/87) | 1.8% | (4/224) |
 BLCA | 442 | 2.7% | (64/2404) | 1% | (1/104) | 1.6% | (7/443) |
 KICH | 407 | 3.7% | (2/54) | – |  | – |  |
 CESC | 230 | 1.4% | (25/1815) | 0% | (0/52) | – |  |
 HNSC | 204 | 0.9% | (17/1914) | 1.9% | (2/103) | 0% | (0/89) |
 LAML | 158 | 0.7% | (3/413) | 0% | (0/3) | – |  |
 LUAD | 71 | 0.4% | (12/2903) | 5.4% | (2/37) ** | 0% | (0/18) |
 PCPG | 64 | 2% | (1/49) | 0% | (0/5) | – |  |
 BRCA | 24 | 0.1% | (2/2162) | 0% | (0/220) | 0% | (0/36) |
 UCEC | 5 | 0% | (0/6669) | 0% | (0/76) | – |  |
 STAD | 3 | 0% | (1/3695) | 0% | (0/86) | – |  |
 SARC | 2 | 0% | (0/543) | 0% | (0/104) | – |  |
 THCA | 2 | 0% | (0/192) | 0% | (0/3) | 0% | (0/201) |